Acadia pharmaceuticals inc. (ACAD)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Revenues
Collaborative revenue

-

-

-

-

61

120

-

-

-

-

-

Total revenues

339,076

223,807

124,901

17,331

61

120

1,145

4,907

2,067

42,135

6,399

Operating expenses
Cost of product sales

11,344

12,377

9,077

3,075

-

-

-

-

-

-

-

License fees and royalties

8,254

5,953

3,983

1,331

2,500

-

-

-

-

-

-

Research and development

240,385

187,163

149,189

99,284

73,869

60,602

26,722

18,794

17,309

20,579

41,585

Selling, general and administrative

325,638

265,758

255,062

186,456

88,304

32,748

12,720

6,999

7,610

6,462

10,282

Total operating expenses

585,621

471,251

417,311

290,146

164,673

93,350

39,442

25,793

24,919

27,041

51,867

Loss from operations

-246,545

-247,444

-292,410

-272,815

-164,612

-93,230

-38,297

-20,886

-22,852

15,094

-45,468

Interest income, net

11,165

5,348

4,126

2,763

499

755

349

37

87

45

323

Other expense

997

-1,840

-

-

-

-

-

-

-

-

-

Loss before income taxes

-234,383

-243,936

-288,284

-270,052

-164,113

-92,475

-37,948

-

-

-

-

Income tax expense

876

1,256

1,119

1,341

330

-

-

-

-

-

-

Net loss

-235,259

-245,192

-289,403

-271,393

-164,443

-92,475

-37,948

-20,849

-22,765

15,139

-45,145

Net loss per common share, basic and diluted

-1.60

-1.94

-2.36

-2.34

-1.63

-0.95

-0.44

-0.38

-0.44

-

-

Weighted average common shares outstanding, basic and diluted

147,199

126,583

122,600

115,858

100,630

97,248

85,715

55,116

52,183

-

-

Net income (loss) per common share, basic

-

-

-

-

-

-

-

-

-

0.39

-1.20

Net income (loss) per common share, diluted

-

-

-

-

-

-

-

-

-

0.39

-1.20

Weighted average common shares outstanding, basic

-

-

-

-

-

-

-

-

-

38,593

37,476

Weighted average common shares outstanding, diluted

-

-

-

-

-

-

-

-

-

38,720

37,476

Product [Member]
Product sales, net

-

-

-

17,327

-

-

-

-

-

-

-

Product and Service, Other [Member]
Product sales, net

-

-

-

4

-

-

-

-

-

-

-